Revvity RVTY Diagnostics — Depreciation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revvity's diagnostics — depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revvity's diagnostics — depreciation?
- Revvity (RVTY) reported diagnostics — depreciation of $9.56M in Q1 2026.
- How has Revvity's diagnostics — depreciation changed year-over-year?
- Revvity's diagnostics — depreciation increased by 39.6% year-over-year, from $6.85M to $9.56M.
- What is the long-term trend for Revvity's diagnostics — depreciation?
- Over 3 years (2022 to 2025), Revvity's diagnostics — depreciation has grown at a 3.7% compound annual growth rate (CAGR), from $29.94M to $33.4M.
- What does diagnostics — depreciation mean?
- The annual non-cash expense for the wear and tear of equipment used by the diagnostics segment.
- How do you interpret diagnostics — depreciation?
- Stable depreciation is expected; sudden spikes may indicate significant new capital investments or changes in asset useful life estimates.
- How does diagnostics — depreciation compare across companies?
- Standard accounting metric for capital-intensive businesses to track asset consumption.